Health
T-cell study adds to debate over duration of COVID-19 immunity – Reuters
A small but key UK study has found that “cellular immunity” to the pandemic SARS-CoV-2 virus is present after six months in people who had mild or asymptomatic…
LONDON (Reuters) – A small but key UK study has found that cellular immunity to the pandemic SARS-CoV-2 virus is present after six months in people who had mild or asymptomatic COVID-19 – suggesting they might have some level of protection for at least that time.
FILE PHOTO: A 3D-printed coronavirus model is seen in front of a world map and the words “CoronaVirus Disease (Covid-19)” on display in this illustration taken March 25, 2020. REUTERS/Dado Ruvic/Illustration
Scientists presenting the findings,…
-
Business19 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News19 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business23 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business22 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025